Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoma and Thymic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT02633514
What this trial is testing

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Who this might be right for
Thymoma and Thymic Carcinoma
Fudan University
Early research (Phase 1)Looking for participantsNCT03295227
What this trial is testing

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Who this might be right for
Stage III Thymoma AJCC v8Stage IIIA Thymoma AJCC v8Stage IIIB Thymoma AJCC v8+4 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00718809
What this trial is testing

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Who this might be right for
Invasive Thymoma and Thymic CarcinomaRecurrent Thymoma and Thymic CarcinomaStage III Thymoma+2 more
National Cancer Institute (NCI) 21
Not applicableEnrolling By InvitationNCT01385722
What this trial is testing

Molecular Analysis of Thoracic Malignancies

Who this might be right for
Thymus CancerThymomaThymic Carcinoma+3 more
Stanford University 1,000
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableNot Yet RecruitingNCT07328074
What this trial is testing

Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis

Who this might be right for
Thymic Epithelial TumorThymomaThymic Carcinoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 70
Early research (Phase 1)Study completedNCT00314873
What this trial is testing

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Indiana University 11
Testing effectiveness (Phase 2)Study completedNCT01364727
What this trial is testing

Amrubicin in Relapsed or Refractory Thymic Malignancies

Who this might be right for
ThymomaThymus CancerThymic Carcinoma
Heather Wakelee 33
Testing effectiveness (Phase 2)Looking for participantsNCT06186726
What this trial is testing

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Who this might be right for
Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy
Jian Chen 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07750353
What this trial is testing

A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas

Who this might be right for
Unresectable Thymic Carcinoma
National Cancer Center, Japan 35
Early research (Phase 1)Study completedNCT03102320
What this trial is testing

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

Who this might be right for
Neoplasms
Bayer 173
Early research (Phase 1)Ended earlyNCT01165658
What this trial is testing

Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies

Who this might be right for
Non-small Cell Lung CancerSmall Cell Lung CancerCarcinoid+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02049047
What this trial is testing

Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy

Who this might be right for
Thymoma and Thymic Carcinoma
Armando Santoro, MD 41
Testing effectiveness (Phase 2)Ended earlyNCT04469725
What this trial is testing

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 95
Testing effectiveness (Phase 2)Study completedNCT01163552
What this trial is testing

Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity

Who this might be right for
Pleural MetastasesBreast CancerColon Cancer+4 more
St. Luke's-Roosevelt Hospital Center 5
Testing effectiveness (Phase 2)Ended earlyNCT01011439
What this trial is testing

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Tiziana Life Sciences LTD 72
Not applicableLooking for participantsNCT04822077
What this trial is testing

Study on Proton Radiotherapy of Thymic Malignancies

Who this might be right for
CardiotoxicityPulmonary ToxicityThymus Neoplasms
Ass. Prof. Jan Nyman 40
Testing effectiveness (Phase 2)UnknownNCT02364076
What this trial is testing

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Who this might be right for
Thymic CarcinomaThymus NeoplasmsThymus Cancer
Georgetown University 45
Testing effectiveness (Phase 2)Looking for participantsNCT06248515
What this trial is testing

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Who this might be right for
ThymomaThymic Carcinoma
Georgetown University 18
Next Page